QMSdesk

IndustriesGLP laboratories

GLP quality management software with Study Director sign-off

A GLP facility needs the Study Director in control of every study, a QAU that stays independent, and a record of every deviation in the final report. QMSdesk™ GLP quality management software builds all three into the workflow, so your studies hold up when the QAU, management or an inspector looks back.

What GLP quality management software changes for you

01

The Study Director sees it first

Every study deviation goes to the Study Director for a signed review within a day, before the QAU is notified or the investigation begins.

02

The final report is never missing a deviation

The final-report note is a signed step every study deviation passes through. There's no path to closure without it.

03

Your QAU stays independent

Management is notified of every QAU finding as its own step, within 7 days, whoever else has already seen it.

What the rules ask of you, and how QMSdesk supports it

GLP rules protect the integrity of nonclinical safety studies. They come down to three things: the Study Director is in charge of each study, the Quality Assurance Unit checks independently, and every deviation is recorded in the final report. QMSdesk builds all three into the workflow, so a study deviation can't close without them.

Regulation What it asks of you How QMSdesk supports it
21 CFR Part 58 FDA's Good Laboratory Practice for nonclinical laboratory studies. Every study deviation goes to the Study Director for a signed review within 1 day. Management is notified of every QAU finding within 7 days, as §58.35(b)(4) requires.
OECD Principles of GLP (1997) The international GLP standard. The final-report note is a mandatory signed step for every study deviation.
EU GLP Directive 2004/10/EC The EU framework that applies the OECD Principles. Carried by the same GLP profile, with 10-year minimum retention.
21 CFR Part 11 Electronic records and signatures you can trust as much as paper. Electronic signatures and a hash-chained audit trail for every customer.

Every customer also holds BASE, the quality baseline, which carries 21 CFR Part 11, ALCOA+, ISO 9001 and ISO 31000. Running contract studies for sponsors? Add Contract operations for QA-agreement deviations and sponsor-facing roles. See CRO and CDMO.

The GLP profile, step by step

A GLP test facility holds BASE and GLP.

A study deviation workflow in 6 steps

  1. Step 1 of 6

    Reported

    With the study number and study phase.

  2. Step 2 of 6

    Signed step

    Study Director review

    Within 1 day: the decision, the impact on study integrity and whether the protocol needs amending.

  3. Step 3 of 6

    QAU notification

    Within 1 day of that review.

  4. Step 4 of 6

    Investigation

    With the root cause and the correction applied.

  5. Step 5 of 6

    Signed step

    Final-report note

    The note's text and the report section it goes in. The step is mandatory, following OECD GLP's rule that every deviation is noted in the final study report.

  6. Step 6 of 6

    Signed step

    Closed

A QAU finding workflow in 5 steps

  1. Step 1 of 5

    Signed step

    Raised

    Naming the study or facility and the QAU inspector.

  2. Step 2 of 5

    Signed step

    Management notification

    Within 7 days, as 21 CFR 58.35(b)(4) requires. It's tracked on its own, even when the Study Director has already reviewed the finding.

  3. Step 3 of 5

    Response

    Root cause, corrective action and preventive action, due in 30 days.

  4. Step 4 of 5

    Signed step

    QAU verification

    Due in 90 days. An insufficient response goes back for another.

  5. Step 5 of 5

    Signed step

    Closed

Everything else a GLP facility records

Equipment calibration failures, test-item nonconformances and unscheduled observations each have their own event type, on the deviation, nonconformance and incident workflows.

Roles: Study Director and Quality Assurance Unit (QAU), alongside the nine standard roles every organization gets. Retention floor in QMSdesk: 10 years, applied to every record in your organization's QMSdesk.

A missed deadline escalates the record through a reminder ladder, and it never blocks the work.

Questions buyers ask

Can a study deviation close without a final-report note?

No. The final-report note is a signed step on the way to closure, and there's no route that skips it.

How does QMSdesk keep the QAU independent of the Study Director?

Management notification is its own signed step on every QAU finding, due within 7 days, whatever the Study Director has already done. The QAU verifies the response and signs it off.

What happens when a deadline is missed?

The record escalates through a reminder ladder, from the owner to the coordinator to the Quality Manager. It's never blocked, and a late step records the reason for the delay.

Can we run GLP alongside GMP or ISO 17025?

Yes. Profiles combine, and the strictest rule applies: the union of event types and roles, the shortest deadline and the longest minimum retention period. A CDMO running nonclinical GLP studies holds BASE, GMP, Contract operations and GLP. See testing laboratories.

How is QMSdesk priced?

By organization tier, never per seat, and every tier includes every module. See pricing.

Build your regulatory profile

What does your organization do?

Profiles you'd hold

BASE (quality baseline), GLP (nonclinical safety studies)

10 yearsRetention floor
7Regulations
12Workflows

Workflows you record

Incident, Deviation, Nonconformance, Complaint, OOS / OOT investigation, CAPA, Supplier issue (SCAR), Study deviation, QAU finding, Equipment out of calibration, Test item nonconformance, Unscheduled observation

Regulations your profiles carry

ISO 9001 — Quality management systems; ISO 31000:2018 — Risk management; 21 CFR Part 11 — Electronic records and signatures; ALCOA+ data-integrity principles; 21 CFR Part 58 — FDA Good Laboratory Practice; OECD GLP Principles; EU GLP Directive 2004/10/EC

Tell us about your studies. We'll show you QMSdesk working under GLP.

Early-stage and growth teams can apply for the 2026 Early Adopter Program.